Antares Pharma, Inc. (ATRS)

Cash & Short-Term Investments

$62.21M

Quarterly · Period ending: · USD

ATRS logo

ATRS Cash & Short-Term Investments

Latest reported$62.21M
ATRS Quarterly Cash & Short-Term Investments ($2.20M → $62.21M)
High-resolution chart · PNG

ATRS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
62,213,000
67,158,000
57,365,000
45,126,000
55,652,000
53,137,000
52,169,000
51,550,000
50,317,000
45,721,000
41,874,000
40,171,000
23,238,000
27,892,000
28,160,000
28,782,000
28,108,000
31,555,000
37,410,473
43,378,872
23,677,111
27,714,588
31,782,739
36,563,635
42,111,144
47,910,901
47,889,897
49,126,530
26,544,048
40,031,327
48,054,047
56,022,861
60,059,747
63,081,541
70,013,819
69,014,819
68,281,043
73,209,687
30,211,571
29,997,408
30,193,831
31,369,320
26,114,982
33,327,248
13,066,373
9,847,813
10,227,084
11,442,740
11,545,964
13,559,088
15,556,291
7,037,369
10,175,321
13,096,298
15,828,338
20,174,093
23,135,688
26,059,768
25,343,821
12,308,237
12,622,052
7,659,468
8,004,928
9,390,338
10,563,245
2,718,472
3,264,559
4,838,212
7,005,415
9,624,033
11,100,337
13,147,311
15,079,985
1,928,815
2,280,574
305,411
193,998
267,945
566,484
442,678
873,317
1,965,089
4,375,925
5,918,895
8,380,167
223,591
229,792
141,497
49,584
85,136
600,000
1,600,000
2,700,000
2,852,285
700,000
1,600,000
3,700,000
7,283,334
3,400,000
3,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.